InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
7.98
-0.06 (-0.75%)
Jan 17, 2025, 4:00 PM EST - Market closed
InfuSystem Holdings Revenue
InfuSystem Holdings had revenue of $35.32M in the quarter ending September 30, 2024, with 10.69% growth. This brings the company's revenue in the last twelve months to $132.78M, up 8.17% year-over-year. In the year 2023, InfuSystem Holdings had annual revenue of $125.79M with 14.44% growth.
Revenue (ttm)
$132.78M
Revenue Growth
+8.17%
P/S Ratio
1.28
Revenue / Employee
$257,333
Employees
516
Market Cap
169.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 125.79M | 15.87M | 14.44% |
Dec 31, 2022 | 109.91M | 7.53M | 7.36% |
Dec 31, 2021 | 102.38M | 5.79M | 5.99% |
Dec 31, 2020 | 96.60M | 15.52M | 19.14% |
Dec 31, 2019 | 81.08M | 13.94M | 20.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
INFU News
- 2 months ago - InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024 - Business Wire
- 2 months ago - InfuSystem Appoints Ronald Hundzinski to the Board of Directors - Business Wire
- 2 months ago - InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - InfuSystem Reports Third Quarter 2024 Financial Results - Business Wire
- 2 months ago - InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024 - Business Wire
- 4 months ago - InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - Business Wire
- 4 months ago - InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC - Business Wire
- 4 months ago - InfuSystem to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024 - Business Wire